Buy or sell Calibrate stock pre IPO via an EquityZen fund
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
About Calibrate Stock
Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.
Chief Medical Officer
Chief Marketing Officer
Director, Business Operations